.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
US Department of Justice
Medtronic
Colorcon
Teva
Cerilliant
Boehringer Ingelheim
Merck
Moodys
Chinese Patent Office

Generated: December 14, 2017

DrugPatentWatch Database Preview

CAM-METRAZINE Drug Profile

« Back to Dashboard

Which patents cover Cam-metrazine, and when can generic versions of Cam-metrazine launch?

Cam-metrazine is a drug marketed by Abc Holding, Camall, and Chartwell Rx. and is included in six NDAs.

The generic ingredient in CAM-METRAZINE is phendimetrazine tartrate. There are five drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Abc HoldingCAM-METRAZINEphendimetrazine tartrateTABLET;ORAL085511-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Chartwell RxCAM-METRAZINEphendimetrazine tartrateTABLET;ORAL085318-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
CamallCAM-METRAZINEphendimetrazine tartrateTABLET;ORAL085756-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Chartwell RxCAM-METRAZINEphendimetrazine tartrateTABLET;ORAL083922-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Chartwell RxCAM-METRAZINEphendimetrazine tartrateTABLET;ORAL085321-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Chartwell RxCAM-METRAZINEphendimetrazine tartrateTABLET;ORAL085320-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Julphar
Daiichi Sankyo
Accenture
UBS
Express Scripts
Dow
Harvard Business School
Boehringer Ingelheim
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot